![](https://ucarecdn.com/7a769ddf-914f-46af-84d3-cf7d6f976905/-/format/auto/-/preview/3000x3000/-/quality/lighter/Hero%20Solutions%20AK%20-02.png)
![](https://ucarecdn.com/4cfc4f9b-b3d1-4c96-8c16-c97119ad7d56/-/format/auto/-/preview/3000x3000/-/quality/lighter/Hero%20Solutions%20AK%20-01.png)
What is AK?
Actinic Keratosis
Actinic keratosis (AK) is a common precancerous condition of SCC that affects nearly 60 million individuals in the United States. The presence of AK is also considered a marker for increased risk of developing BCC.
Approximately 75,000 new cases of melanoma and nearly 2 million cases of non-melanoma skin cancer (NMSC) are diagnosed in the U.S. each year.
The development of non-melanoma skin cancers, squamous cell carcinoma [SCC] and basal cell carcinoma [BCC], has been linked to repeated exposure to sun radiation over many years, whereas melanoma is also linked to the severity of sunburn